Alcidion secures $35M UK health tech contract

Australian healthcare technology provider Alcidion Group (ASX:ALC) has secured a landmark seven-year contract with the University Hospitals Sussex NHS Foundation Trust to deploy its flagship Miya Precision platform as the Trust’s new electronic patient record system.

The agreement features an initial total contract value of approximately $35 million, with extension rights up to 10 years that could elevate the potential TCV to $49 million.

Alcidion expects to recognise roughly $8.5 million of this revenue in FY26, largely driven by an upfront licence fee.

Selected via a highly competitive tender process, the deployment marks Alcidion's third major EPR platform contract in the United Kingdom.

Implementation is scheduled to begin immediately, spanning an estimated 18-month period toward a phase-one go-live target in June 2027.

The modular platform will integrate Miya Observations and Assessments—which is already active at the Trust—alongside an upfront $2 million third-party medications management module.

The rollout includes Alcidion’s virtual care module, marking its inaugural deployment for a UK customer to support remote patient monitoring and out-of-hospital treatment.

The Trust also retains future options to scale the system with Miya Emergency and Patient Administration System modules.

UHSussex is one of the UK’s largest acute trusts, operating seven hospitals and employing nearly 20,000 staff under the Surrey and Sussex Integrated Care Board.

Serving approximately one million people, the trust manages over 1.5 million outpatient appointments, emergency visits, and surgical cases annually.

At the time of reporting, Alcidion Group's share price was $0.12.